Article

Susan Urba, MD, Discusses Treatments for CINV

Susan Urba, MD, Medical Director, Symptom Management & Supportive Care Program, University of Michigan, says that preventative medications given prior to treatment are necessary in order to improve the quality of life for patients with chemotherapy-induced nausea and vomiting (CINV).

Susan Urba, MD, Medical Director, Symptom Management & Supportive Care Program, University of Michigan, says that preventative medications given prior to treatment are necessary in order to improve the quality of life for patients with chemotherapy-induced nausea and vomiting (CINV).

Dr Urba says that vomiting is well controlled, but nausea is still a problem despite the preventative medication. "For now, prevention is the key," Dr Urba said. "Giving the adequate drugs for the category that the patient is in, and hopefully the patient's quality of life will improve."

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Dr Hans Lee
Dr María Díez Campelo
Nicole Bajic, MD
Interview with Miriam Freimer, MD, The Ohio State University Wexner Medical Center
Merrill H. Stewart, MD
Dr Carrie Kitko
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo